Terminology
Plasmapheresis and plasma exchange are terms that are often used synonomously in today's literature. However plasma exchange has become possible only since the introduction of efficient cell separation techniques. A cell separator machine can remove large volumes of plasma, necessitating replacement with whole or fractionated plasma or a plasma substitute, to maintain intravascular colloid osmotic pressure. Plasmapheresis is the removal of plasma only, with the return of the cellular blood components, as first described in 1914.1 The original term being derived from the Greek apheresis meaning a withdrawal. Technique Plasma exchange is the continuous or discontinuous flow of anticoagulated blood into some form of centrifugal device which enables plasma separation to occur. Plasma is removed and an equivalent volume of replacement material is recombined with the patient's cells and returned to the patient. An example of the continuous flow system is the IBM 2997, and of the discontinuous flow system is the Haemonetics Model 30 or V50. Each has its own particular advantage, but in a discontinuous flow system fluid balance requires more careful management and it takes longer for a set volume because of the intermittent nature of the procedure. The It is not the purpose of this review to deal in depth with each disease but rather to select examples of the principles concerned from each group, together with any reports of usage in children. Immune complex mediated. The logic of using plasma exchange for the treatment of immune complex disease is based on the following concepts: removal of the immune complex load, removal of antigen or antibody or both of these, alteration of the size and lattice formation of the immune complex and thereby possibly its pathogenicity, unblocking of the reticuloendothelial system, and the removal of non-specific inflammatory mediators.
Although the potential role of plasma exchange in immune complex disease appears greater than in antibody-mediated disease, the results are difficult to assess as many of these diseases are known to have spontaneous fluctuations in activity and most patients have been subjected to treatment with multiple drugs before the use of plasma exchange.
Systemic lupus erythematosus
The removal of immune complexes by plasma exchange in severe unresponsive systemic lupus erythematosus has been shown to be beneficial.2021 Furthermore, studies on the levels of immune complexes in such cases have shown significant reductions in concentrations after plasma exchange. These levels continue to fall beyond the end of the plasma exchange period, supporting the concept that clearance of the reticuloendothelial system blockade is also achieved. Occasionally long-term treatment is indicated-for example in hypercholesteraemia-but this is a practicable proposition only if the interval between exchanges can be lengthened while still maintaining therapeutic benefit. At present plasma exchange is a fairly crude form of treatment, but with the advent of adsorption columns future prospects are brighter making the method more specific and obviating the need for any substitution fluid. The whole procedure then becomes cheaper, safer, and more satisfactory.
Cost
As therapeutic effectiveness is difficult to ascertain, the cost of the procedure must be taken into consideration. The current cost of undertaking one plasma exchange in childhood in terms of disposable equipment and plasma protein fraction used, is in the region of £150. This figure does not take into account the capital and revenue expenditure incurred by the running of an efficient cell separator unit; without experienced staff the procedure is impossible to carry out. It is foolhardy and potentially hazardous to attempt therapeutic cell separation procedures only occasionally with an inexperienced team, but the costs of running such units are high.
Conclusion
Plasma exchange is an exciting field which has given a new therapeutic approach to a variety of different disorders. Furthermore it has opened up the possibility of a combined approach using adsorption columns for the removal of the specific unwanted substance. By enabling the enrichment or depletion of a particular substance in the circulation it can be used as an investigative tool in the study of that substance's role in the disease process.
It is important that such studies are undertaken in units in which full laboratory assessment is possible and that controlled trials are undertaken in diseases where the therapeutic efficacy of plasma exchange is in doubt. To quote from a recently written article on plasma exchange, 'Its excessive use beyond its natural limitations could overshadow its intrinsic merits and hasten its decline.'"
